We are living in trying times.
The novel Coronavirus COVID-19 pandemic has affected all of us in varied ways and continues to transform our world every single day. Some of us have lost our beloved patients, colleagues, and family members. Some of our health care workers have heroically lost their lives in the front line. Most of us have embarked on alternative health care models such as telehealth, distancing ourselves from each other. For some, the “touch” which was so vital for our heart failure patients and clinicians, is now through virtual screens.
For others, the fight is in the front lines, in ICUs, acute COVID-19 care units, ED and the field hospitals where the “touch” is inevitable. Most, without adequate resources, without PPE or ventilators. Some of us are relentlessly trying to lead research and decipher the scientific code to contain, treat, and cure while the urgency escalates.
Resource Center. We have created the HFSA Coronavirus (COVID-19) Resource Center, which houses information about Coronavirus for both heart failure providers and heart failure patients and caregivers as we work our way through this pandemic.
News about Coronavirus. We are constantly updating our HFSA News section to provide you the latest information on the virus and its impact on the cardiology community and our patients.
Patients taking ACE-i and ARBs who contract COVID-19. HFSA worked with the American Heart Association and the American College of Cardiology to produce a statement urging these patients to continue taking their treatment, unless otherwise advised by their physician.
Heart Failure Patients and COVID-19. A statement was developed for heart failure patients and their caregivers on protections during the Coronavirus pandemic and recommendations on what to do if you contract the virus. Special thanks to the HFSA Patient Committee for their work in writing this important and timely statement.
Telemedicine and COVID-19. Eiran Gorodeski, MD of Case Western Reserve University is leading a writing group in developing a statement on the use of telemedicine for heart failure patients in the era of COVID-19.
Call for COVID-19 papers by JCF. The HFSA’s Journal of Cardiac Failure is seeking reports related to the COVID-19 global pandemic, in particular, papers including case series describing the development of heart failure, myocarditis and other cardiac complications of viral infection, pathophysiology and related topics. When feasible, the papers will be rapid tracked. Go here for instructions to authors for information on submission. Email Anna Leong of the HFSA staff with any questions.
New Learning Center. With the launch of the new HFSA Learning Center, we are offering a 10% discount to HFSA members on all of the cutting-edge content in the Learning Center. With the recent cancellation of so many cardiology and heart failure meetings across the globe, we want to help you stay up to date with access to critical CME and MOC education.
HFSA meetings. We continue to move forward with our plans to bring you the highest quality education that you need, including the HFSA Board Certification Review Course in Chicago from July 31-August 2 and the 2020 HFSA Annual Scientific Meeting in Cleveland from October 2-5. We recognize the challenges that HFSA members and non-members are facing this year due to the cancellation of meetings. HFSA will be providing you three ways to participate in our meetings: in-person attendance, live streaming during the meeting, and OnDemand after the meeting.
HFSA is with you during the Coronavirus COVID-19 pandemic, and we will continue to provide information and resources to help you get through these trying times. Together, as a profession, we will persevere.
I salute our health care workers who continue the fight with such altruism, resilience, courage and resolve, and send my sincere wishes for health and safety of our heart failure patients, clinicians and community.
Biykem Bozkurt, MD, PhD, FHFSA